Your Global Leader in Stem Cell Market Research
New York, USA, January 31, 2023 – Creative Bioarray, one of the world’s leading biotechnology products and services providers, is dedicated to becoming a profitable premier provider of quality life science research reagents and services helping customers develop innovative methods and products. [Read more…]
Colossal Biosciences, the world’s first de-extinction company, has announced an oversubscribed $150M Series B financing led by United States Innovative Technology Fund (“USIT”), with participation from Breyer Capital, WestRiver Group, Bob Nelsen, Animal Capital, Victor Vescovo, In-Q-Tel, Animoca Brands, Peak 6, BOLD Capital, and Jazz Ventures, among others. [Read more…]
From β-islets for diabetes (1) to dopaminergic neurons (Figure 1) for Parkinson’s disease (2), induced pluripotent stem cell (iPSC)-derived, haplotyped, and multiplex-engineered allogeneic cell therapeutics empower the development of effective and safe Cell and Gene Therapy Products (CGTs) that could be manufactured on a large scale in a cost-effective manner and provide a functional cure for diseases that plague humankind today. [Read more…]
